Clover Health Investments Corp (NASDAQ:CLOV) has a beta value of 1.92 and has seen 5.55 million shares traded in the last trading session. The company, currently valued at $1.52B, closed the last trade at $2.98 per share which meant it lost -$0.02 on the day or -0.67% during that session. The CLOV stock price is -63.42% off its 52-week high price of $4.87 and 49.66% above the 52-week low of $1.50. If we look at the company’s 10-day average daily trading volume, we find that it stood at 11.14 million shares traded. The 3-month trading volume is 7.85 million shares.
The consensus among analysts is that Clover Health Investments Corp (CLOV) is Hold stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 1 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.03.
Clover Health Investments Corp (NASDAQ:CLOV) trade information
Sporting -0.67% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CLOV stock price touched $2.98 or saw a rise of 8.31%. Year-to-date, Clover Health Investments Corp shares have moved 104.11%, while the 5-day performance has seen it change -2.30%. Over the past 30 days, the shares of Clover Health Investments Corp (NASDAQ:CLOV) have changed 1.71%. Short interest in the company has seen 22.28 million shares shorted with days to cover at 3.79.
Wall Street analysts have a consensus price target for the stock at $2.5, which means that the shares’ value could drop -19.2% from current levels. The projected low price target is $1.8 while the price target rests at a high of $6.0. In that case, then, we find that the current price level is -101.34% off the targeted high while a plunge would see the stock lose 39.6% from current levels.
Clover Health Investments Corp (CLOV) estimates and forecasts
The company’s shares have lost -18.13% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 35.84%.
4 analysts offering their estimates for the company have set an average revenue estimate of 468.3M for the current quarter. 4 have an estimated revenue figure of 466.94M for the next ending quarter. Year-ago sales stood 356.26M and 330.99M respectively for this quarter and the next, and analysts expect sales will grow by 31.45% for the current quarter and 35.84% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -237.67% over the past 5 years.
CLOV Dividends
Clover Health Investments Corp is expected to release its next earnings report on 2025-May-06 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders
Insiders own 3.90% of the company shares, while shares held by institutions stand at 26.16% with a share float percentage of 27.22%. Investors are also buoyed by the number of investors in a company, with Clover Health Investments Corp having a total of 244.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 17.35 million shares worth more than $21.33 million. As of 2024-06-30, VANGUARD GROUP INC held 3.5581% of shares outstanding.
The other major institutional holder is RENAISSANCE TECHNOLOGIES LLC, with the holding of over 11.27 million shares as of 2024-06-30. The firm’s total holdings are worth over $13.86 million and represent 2.3123% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 2.88% shares in the company for having 12.01 shares of worth $35.8 million while later fund manager owns 6.42 shares of worth $19.14 million as of Mar 31, 2025 , which makes it owner of about 1.54% of company’s outstanding stock.
